NDC 51672-1279-01 - Fluocinonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1279
- Requested NDC
- 51672-1279-01
- Package NDCs from labels
- 51672-1279-1, 51672-1279-2, 51672-1279-3, 51672-1279-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-12-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fluocinonide - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-12-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1279-1 | Fluocinonide | 1 in 1 CARTON | GEL | 1 | 8 | |
| 51672-1279-1 | Fluocinonide | 15 g in 1 TUBE | GEL | 15 | 8 | |
| 51672-1279-2 | Fluocinonide | 30 g in 1 TUBE | GEL | 30 | 8 | |
| 51672-1279-2 | Fluocinonide | 1 in 1 CARTON | GEL | 1 | 8 | |
| 51672-1279-3 | Fluocinonide | 1 in 1 CARTON | GEL | 1 | 8 | |
| 51672-1279-3 | Fluocinonide | 60 g in 1 TUBE | GEL | 60 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1279 | FLUOCINONIDE CREAM FLUOCINONIDE GEL FLUOCINONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 6 package rows | 20240823_b0bc89a9-c9d5-4adb-9785-2d4487c4c656.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1279-1 | GM - Gram | 51672-1279 | 9fbfb81e-7840-4eb7-8fff-ef706dc3060e | 1 | 2012-07-24 |
| 51672-1279-2 | GM - Gram | 51672-1279 | 25cef57b-43c9-4315-94d5-ff490563a357 | 1 | 2012-07-24 |
| 51672-1279-3 | GM - Gram | 51672-1279 | 2287d5cd-41a5-4955-8b57-c1cd2723231b | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FLUOCINONIDE | FLUOCINONIDE | QUAGEN PHARMACEUTICALS LLC | 272a4467-b5f8-430b-8fab-7fbb07dc8114 | 2025-08-01 | Adverse reactions | 2W4A77YPAN |
| Asteroid | MENTHOL, PETROLATUM, ZINC OXIDE | HEALTHTEX LIMITED | 29d1e46d-0189-4f9e-9963-8a9de2757f28 | 2025-07-30 | Warnings | 4T6H12BN9U |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 99b63d62-1cf0-4f28-8760-773917c2538a | 2025-07-29 | Warnings | 6DC9Q167V3 |
| LEADER Mineral Oil | MINERAL OIL | Cardinal Health, 110 dba Leader | 7d4f8fa3-8203-5523-e053-2991aa0aba1a | 2025-07-28 | Warnings | T5L8T28FGP |
| ProCure SkinGuard | PETROLATUM 49.9% | Twin Med LLC | 3a1721f6-1bb0-cd47-e063-6394a90a148e | 2025-07-25 | Warnings | 4T6H12BN9U |
| AD PREVENT Original | AD PREVENT ORIGINAL | WellSpring Pharmaceutical Corporation | cf73246e-81c1-42e9-a107-dc6c99cf7d01 | 2025-07-24 | Warnings | 4T6H12BN9U |
| Doctor Butler Hemorrhoid and Fissure Advanced Formula | GLYCERIN 37.5%, LANOLIN 12.5%, LIDOCAINE 4%, ZINC OXIDE 5% | Beyond Health, PA | d2a769e2-afd0-aed2-e053-2995a90ad429 | 2025-07-23 | Warnings | PDC6A3C0OX |
| Dr Butlers Soothing Incontinence | MINERAL OIL 59.8%, PETROLATUM 36.0% | Beyond Health PA | 3a9d3796-fd05-fe57-e063-6294a90a0ac6 | 2025-07-23 | Warnings | 4T6H12BN9U T5L8T28FGP |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | ATLANTIC BIOLOGICALS CORP. | c9688f06-b6db-4afb-b8ff-ef5fb8bf9946 | 2025-07-22 | Warnings | G2M7P15E5P |
| A and D plus E | VITAMIN A, D AND E OINTMENT | Derma Sciences Canada Inc. | 35aca592-bfd0-652f-e063-6394a90ac53e | 2025-07-22 | Warnings | 4T6H12BN9U |
| Petroleum Jelly | PETROLATUM | Derma Sciences Canada Inc. | 3a895e6c-da8d-db9b-e063-6394a90ace40 | 2025-07-22 | Warnings | 4T6H12BN9U |
| Cold Sore Fast-Acting Pain Relief | GLYCERIN AND LIDOCAINE | Blistex Inc. | c7511322-dd6c-441c-bf7d-ad4f0c14956a | 2025-07-22 | Warnings | PDC6A3C0OX |
| Cureforte Breath Reset | MOUTH SPRAY | STEEL CITY HEALTH PRIVATE LIMITED | 38ddf1a7-29ab-cb8d-e063-6294a90ad34c | 2025-07-21 | Warnings | PDC6A3C0OX |
| GoodSense Hemorrhoidal Pain Relief | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Perrigo Direct, Inc | 2e5f699d-45e8-6451-e063-6394a90a8ad8 | 2025-07-20 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| SilkTears | GLYCERIN OPHTHALMIC SOLUTION | SilkTears | 3866e2c1-051b-0b01-e063-6394a90af5cf | 2025-07-16 | Warnings | PDC6A3C0OX |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | XF417D3PSL |
| Eyeleve MGD | MINERAL OIL | Bruder Healthcare | 145b66e2-00e1-410e-8539-e12ffc4f6f82 | 2025-07-15 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.